0000899243-22-033781.txt : 20221018 0000899243-22-033781.hdr.sgml : 20221018 20221018215040 ACCESSION NUMBER: 0000899243-22-033781 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221018 FILED AS OF DATE: 20221018 DATE AS OF CHANGE: 20221018 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Simon Mark CENTRAL INDEX KEY: 0001400717 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39103 FILM NUMBER: 221317126 MAIL ADDRESS: STREET 1: C/O AMICUS THERAPEUTICS, INC. STREET 2: 6 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cabaletta Bio, Inc. CENTRAL INDEX KEY: 0001759138 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2929 ARCH STREET STREET 2: SUITE 600 CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: (267) 759-3100 MAIL ADDRESS: STREET 1: 2929 ARCH STREET STREET 2: SUITE 600 CITY: PHILADELPHIA STATE: PA ZIP: 19104 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-10-18 0 0001759138 Cabaletta Bio, Inc. CABA 0001400717 Simon Mark C/O CABALETTA BIO, INC. 2929 ARCH STREET, SUITE 600 PHILADELPHIA PA 19104 1 0 0 0 Common Stock 2022-10-18 4 P 0 118000 0.977 A 136144 D Common Stock 2022-10-18 4 P 0 7000 0.9764 A 7000 I By Spouse The price reported in Column 4 is a weighted average price. These shares were purchased at prices ranging from $0.9315 to $0.99, inclusive. The reporting person has provided to the Issuer, and undertakes to provide any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were purchased at prices ranging from $0.9375 to $0.9899, inclusive. /s/ Michael Gerard, Attorney-in-Fact 2022-10-18